Cocrystal Pharma Inc (COCP)
NASDAQ:COCP
Total Valuation
Cocrystal Pharma has a market cap or net worth of $20.82M. The enterprise value is $9.96M.
Market Cap$20.82M
Enterprise Value$9.96M
Share Statistics
Cocrystal Pharma has 13,785,759 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,785,759
Owned by Insiders45.08%
Owned by Institutions0.72%
Financial Efficiency
Cocrystal Pharma’s return on equity (ROE) is -1.39 and return on invested capital (ROIC) is -115.10%.
Return on Equity (ROE)-1.39
Return on Assets (ROA)-0.91
Return on Invested Capital (ROIC)-115.10%
Return on Capital Employed (ROCE)-1.20
Revenue Per Employee0.00
Profits Per Employee-802.82K
Employee Count11
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Cocrystal Pharma is ―. Cocrystal Pharma’s PEG ratio is 0.02.
PE Ratio―
PS Ratio0.00
PB Ratio1.75
Price to Fair Value1.75
Price to FCF-1.35
Price to Operating Cash Flow-2.03
PEG Ratio0.02
Income Statement
In the last 12 months, Cocrystal Pharma had revenue of 0.00 and earned -8.83M in profits. Earnings per share was -0.78.
Revenue0.00
Gross Profit0.00
Operating Income-9.02M
Pretax Income-8.83M
Net Income-8.83M
EBITDA-8.64M
Earnings Per Share (EPS)-0.78
Cash Flow
In the last 12 months, operating cash flow was -8.38M and capital expenditures -12.56K, giving a free cash flow of -8.39M billion.
Operating Cash Flow-8.38M
Free Cash Flow-8.39M
Free Cash Flow per Share-0.61
Dividends & Yields
Cocrystal Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.84
52-Week Price Change19.84%
50-Day Moving Average1.03
200-Day Moving Average1.23
Relative Strength Index (RSI)78.88
Average Volume (3m)3.12M
Important Dates
Cocrystal Pharma upcoming earnings date is May 18, 2026, TBA (Confirmed).
Last Earnings DateMar 31, 2026
Next Earnings DateMay 18, 2026
Ex-Dividend Date―
Financial Position
Cocrystal Pharma as a current ratio of 3.68, with Debt / Equity ratio of 23.77%
Current Ratio3.68
Quick Ratio3.68
Debt to Market Cap0.00
Net Debt to EBITDA0.64
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Cocrystal Pharma has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Cocrystal Pharma EV to EBITDA ratio is -0.64, with an EV/FCF ratio of -0.67.
EV to Sales0.00
EV to EBITDA-0.64
EV to Free Cash Flow-0.67
EV to Operating Cash Flow-0.68
Balance Sheet
Cocrystal Pharma has $7.03M in cash and marketable securities with $1.50M in debt, giving a net cash position of $5.52M billion.
Cash & Marketable Securities$7.03M
Total Debt$1.50M
Net Cash$5.52M
Net Cash Per Share$0.40
Tangible Book Value Per Share$0.56
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Cocrystal Pharma is $6.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.00
Price Target Upside450.46% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast49.10%